Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating and gas are among the most commonly reported side effects of Mounjaro (tirzepatide). They tend to be most noticeable in the first few weeks of treatment or after a dose increase, as the body adjusts to slower gastric emptying — the same mechanism that makes the medicine effective for weight loss. For most people they settle down considerably within a fortnight, though the experience varies. Mounjaro is a prescription-only medicine; a clinician assesses suitability before any treatment is started.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide acts on two gut-hormone receptors (GIP and GLP-1) which together slow the rate at which food leaves the stomach. This is largely why people feel full on much smaller portions. The same slowing, though, means food ferments in the gut for longer than usual, and gas production goes up as a result. Bloating on Mounjaro is the physical expression of that trapped gas.
The NHS medicines page for tirzepatide lists bloating, burping and flatulence alongside nausea and diarrhoea as part of the expected gastrointestinal profile of the drug. None of this reflects anything going wrong; it reflects the mechanism working exactly as intended. What varies is how strongly any individual feels it.
People who already tend towards slower gut motility (those with a history of constipation, for example) sometimes notice more pronounced bloating than people whose digestion runs faster. Starting dose and speed of titration also matter: moving up through the dose schedule too quickly before the gut has adapted is a common trigger for a return of symptoms even in people who had settled down.
For most people the pattern follows a predictable arc. Bloating and gas on Mounjaro are usually worst in the first two to four weeks on a new dose, then gradually subside as the gut adjusts. A large proportion of those who experience it say symptoms become barely noticeable by the time they reach their maintenance dose, provided titration has been paced carefully by their prescriber.
There is a second common pattern: symptoms that had largely disappeared return after a dose increase. This is not a sign of a new problem, it is the adjustment cycle restarting at a higher level. The SURMOUNT-1 trial, published in the New England Journal of Medicine, documented gastrointestinal events as the most frequently reported adverse effects overall, with the majority rated mild to moderate and most resolving without stopping treatment.
If you are finding the pattern difficult to predict or manage, it is worth looking at the practical approaches that can ease bloating on Mounjaro, there are concrete dietary and timing changes that help. Bloating that is worsening rather than improving after several weeks on a stable dose, or that is accompanied by significant stomach pain, warrants a conversation with your prescriber rather than simply waiting it out. For a deeper look at when abdominal discomfort crosses into something more concerning, this page on Mounjaro bloating and stomach pain covers the distinction clearly.
A few practical changes make a notable difference for most people. Meal size is the biggest lever: because the stomach is emptying slowly, eating the same volume as before treatment almost guarantees discomfort. Smaller, more frequent meals (rather than three large ones) give the gut less to work with at any one time.
Fizzy drinks are worth pausing entirely, at least during the first month. The carbonation adds gas on top of what the gut is already producing, and the result is predictably uncomfortable. Tea and plain water are fine; sparkling water and diet cola are not your friends right now.
High-FODMAP foods (onions, garlic, pulses, cauliflower and similar) ferment readily in the colon and worsen gas production. Reducing them temporarily, particularly in the first weeks of a new dose, often makes a meaningful difference. Eating slowly and not talking while eating (harder than it sounds at a family dinner) reduces the volume of air swallowed.
Timing matters too. Taking Mounjaro on a day when you have a lighter schedule the next morning (rather than, say, the evening before a long day at the office) gives you a quieter window if nausea and bloating coincide. Some people also notice unexpected discomforts alongside bloating, and if you are experiencing hip pain on Mounjaro, that page explains why musculoskeletal symptoms can occur and what to do about them. For more structured guidance on dietary changes, this page on stopping bloating on Mounjaro goes into specific food strategies in more detail.
Ordinary bloating and flatulence are uncomfortable but not medically urgent. There are, however, symptoms that sit in a different category entirely. In January 2026, the MHRA's Yellow Card reporting system was highlighted alongside a Drug Safety Update on GLP-1 medicines and acute pancreatitis, a rare but serious condition. The warning sign to watch for is severe, persistent abdominal pain that radiates towards the back, which may or may not come with vomiting. That is not bloating. That needs same-day medical assessment, not a dietary tweak.
Similarly, if bloating is so severe that you cannot keep fluids down (whether from accompanying nausea, vomiting or diarrhoea) dehydration and potential kidney strain become real concerns. It is also worth knowing that bloating after stopping Mounjaro is something some people experience, and that page explains why it happens and how long it typically lasts. Drink small sips frequently and contact your prescriber or GP if you cannot manage it.
If you are ever unsure whether what you are feeling is within the normal range of adjustment or something that needs attention, the safest answer is always to ask. Our support team is available seven days a week, and the team at our clinical team reviews clinical concerns the same day. You can also report any suspected side effects directly through the MHRA's Yellow Card scheme, a link is on that page.
Mounjaro is a prescription medicine for adults, and a GPhC-registered prescriber assesses the full picture before treatment begins and at every repeat. If you are exploring whether tirzepatide might be appropriate for you, starting a free consultation is the right first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.